Cell line cross-contamination in biomedical research: A call to prevent unawareness

Acta Pharmacologica Sinica

Volumn 29, Issue 7, 2008, Pages 877-880

  Rojas, Armando ^a   Gonzalez, Ileana ^a   Figueroa, Héctor ^a  

^a UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

Author keywords

Cross contamination; Falsec ell lines; Pharmacological screening

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CELL LINE CROSS CONTAMINATION; CONTAMINATION; CROSS REACTION; DIAGNOSTIC ERROR; FUNDING; HUMAN; MEDICAL RESEARCH; NONHUMAN; PEER REVIEW; QUALITY CONTROL; RESOURCE MANAGEMENT; STANDARD; CELL LINE; DRUG RESISTANCE; HEALTH CARE FACILITY; LETTER; PHYSIOLOGY; TUMOR CELL LINE;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; CELL LINE; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS;

EID: 58749084438     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00809.x     Document Type: Article

References (39)

1. Combes RD. The use of human cells in biomedical research and testing. Altern Lab Anim 2004; 32: 43-9.
2. Nardone RM. Eradication of cross-contaminated cell lines: A call for action. Cell Biol Toxicol 2007; 23: 367-72.
3. Lacroix M. Persistent use of "false" cell lines. Int J Cancer 2008; 122: 1-4.
4. Rothfels FH, Axelrad AA, Siminovitch L, McCulloch EA, Parker RC. The origin of altered cell lines from mouse, monkey, and man, as indicated by chromosome and transplantation studies. In: Begg RW, editor. Canadian Cancer Conference, Proceedings of the 3rd Canadian Cancer Research Conference. 1958, June 17-21, Ontario, Vol 3. New York: Academic Press Inc; 1959. p 189-214.
5. Gartler SM. Genetic markers as tracers in cell culture. J Natl Cancer Inst 1967; 26: 167-95.
6. Lavappa KS, Macy ML, Shannon JE. Examination of ATCC stocks for HeLa marker chromosomes in human cell lines. Nature 1976; 259: 211-3.
7. Nelson-Rees WA, Daniels DW, Flandermeyer RR. Cross-contamination of cells in culture. Science 1981; 212: 446-52.
8. Master JR. HeLa cell 50 years on: the good, the bad and the ugly. Nat Cancer Rev 2002; 2: 315-9.
9. MacLeod RAF, Dirks WG, Matsuo Y, Kaufmann M, Milch H, Drexler HG. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Intl J Cancer 1999; 83: 555-63.
10. Buehring GC, Elizabeth A, Michael J. Cell line cross-contamination: how aware are mammalian cell culturists of the problem and how to monitor it? In Vitro Cell Dev Biol Anim 2004; 40: 211-5.
11. Masters JR. DNA profiling and the authentication of cell lines. In Vitro Cell Dev Biol 2005; 41: (abstract) 6A.
12. van Bokhoven A, Varella-Garcia M, Korch C, Hessels D, Miller GJ. Widely used prostate carcinoma cell lines share common origins. Prostate 2001; 47: 36-51.
13. Varella-Garcia M, Boomer T, Miller GJ. Karyotypic similarity identified by multiplex-FISH relates four prostate adenocarcinoma cell lines: PC-3, PPC-1, ALVA- 31, and ALVA-41. Genes Chromosomes Cancer 2001; 31: 303-15.
14. Iizumi T, Yazaki T, Kanoh S, Kondo I, Koiso K. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J Urol 1987; 137: 1304-6.
15. Muraki J, Addonizio JC, Choudhury MS, Fischer J, Eshghi M, Davidian MM, et al. Establishment of new human prostat ic cancer cell line (JCA-1). Urology 1990; 36: 79-84.
16. van Bokhoven A, Varella-Garcia M, Korch C, Gary J. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 2001; 61: 6340-4.
17. Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH. Overexpression of a novel anionic glutathione t ransferase in multidrug-resistant human breast cancer cells. J Biol Chem 1986; 261: 15544-9.
18. Cowan KH, Batist G, Tulpule A, Sinha BK, Myers CE. Similar biochemical changes associated with multidrug resistance in human breast cancer cel ls and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci USA 1986; 83: 9328-32.
19. Monks A, Scudiero D, Skehen P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991; 83: 757-66.
20. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, et al. An information-intensive approach to the molecular pharmacology of cancer. Science 1997; 275: 343-9.
21. Scherf U, Ross DT, Walthan M, Smith LH, Lee JK, Tanabe L, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000; 24: 236-44.
22. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003; 100: 14229-34.
23. Scudiero DA, Monks A, Sausville EA. Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen. J Natl Cancer Inst 1998; 90: 862.
24. Liscovitch M, Ravid D. A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADRRES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett 2007; 245: 350-2.
25. Drexler HG, DirksWG, Matsuo Y, MacLeod RAF. False leukemia- lymphoma cell lines: an update on over 500 cell lines. Leukemia 2003; 17: 416-26.
26. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006; 176: 1-40.
27. Rojas A, Morales MA. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res 2004; 35: 1-11.
28. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990; 26: 265-74.
29. Takahashi K, Sawasaki Y. Rare spontaneously transformed human endothelial cell line provides useful research tool. In Vitro Cell Dev Biol 1992; 28A: 380-2.
30. Dirks WG, MacLeod RA, Drexler HG. ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev Biol Anim 1999; 35: 558-9.
31. Rojas A, González I, Figueroa H. Letter to the Editor: Use and misuse of ECV-304 cell line. Eur J Neurol 2008; 15: e8.
32. Suda K, Rothen-Rutishauser B, Günthert M, Wunderli-Allenspach H. Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim 2001; 37: 505-14.
33. Master JR. False cell lines: the problem and a solution. Cytotechnology 2002; 39: 69-74.
34. Nims RW, Shoemaker AP, Bauernschub MA, Rec LJ, Harbell JW. Sensitivity of isoenzyme analysis for the detection of interspecies cell line cross-contamination. In Vitro Cell Dev Biol Anim 1998; 34: 35-9.
35. Rush LJ, Heinonen K, Mrózek K, Wolf BJ, Abdel-Rahman M, Szymanska J, et al. Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line. Blood 2002; 99: 1874-6.
36. O'Toole CM, Povey S, Hepburn P, Franks LM. Identity of some human bladder cancer cell lines. Nature 1983; 301: 429-30.
37. Quentmeier H, Osborn M, Reinhardt J, Zaborski M, Drexler HG. Immunocytochemical analysis of cell lines derived from solid tumors. J Histochem Cytochem 2001; 49: 1369-78.
38. Gilbert DA, Reid YA, Gail MH, Pee D, White C, Hay RJ, et al. Application of DNA fingerprints for cell-line individualization. Am J Hum Genet 1990; 47: 499-514.
39. Yoshino K, Iimura J, Saijo K, Iwase S, Fukami K, Ohno T, et al. Essential role for gene profiling analysis in the authentication of human cell lines. Human Cell 2006; 19: 43-8.